https://www.selleckchem.com/pr....oducts/ly3200882.htm
The formulation exhibited comparable cytotoxicity in MDA-MB-231 cells (IC50 = 2.73 μM, 36 h), and inhibited the migration of cancer cells significantly compared to the free drug and unloaded PDA NPs. Furthermore, the unloaded NPs exhibited excellent in vivo compatibility. The study establishes a rigorously optimized protocol for the synthesis of Nic loaded PDA NPs. The biocompatibility, anti-migratory efficacy, and the in vivo non-toxic nature of PDA has been well demonstrated.The design and manufacture of tablets is a challenging pro